TY - JOUR
T1 - What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel
AU - Gül, M.
AU - Luca, B.
AU - Dimitropoulos, K.
AU - Capogrosso, P.
AU - Milenkovic, U.
AU - Cocci, A.
AU - Veeratterapillay, R.
AU - Hatzichristodoulou, G.
AU - Modgil, V.
AU - Russo, G. I.
AU - Tharakan, T.
AU - Kalkanli, A.
AU - Omar, M. I.
AU - Bettocchi, C.
AU - Carvalho, J.
AU - Corona, G.
AU - Jones, T. H.
AU - Kadioglu, A.
AU - Martinez-Salamanca, J. I.
AU - Serefoglu, E. C.
AU - Verze, P.
AU - Minhas, S.
AU - Salonia, A.
AU - Salonia, Andrea
AU - Minhas, Suks
AU - Bettochi, Carlo
AU - Corona, Giovanni
AU - Salamanca, J. I.Martínez
AU - Kadıoğlu, Ateş
AU - de Carvalho, J. P.Pereira
AU - Jones, Hugh
AU - Verze, Paolo
AU - Şerefoğlu, Ege Can
AU - Capogrosso, Paolo
AU - Boeri, Luca
AU - Cocci, Andrea
AU - Dimitropoulos, Konstantinous
AU - Falcone, Marco
AU - Gül, Murat
AU - Hatzichristodoulou, Georgios
AU - Kalkanli, Arif
AU - Milenkovic, Uros
AU - Morgado, Afonso
AU - Tharakan, Tharu
AU - Czeloth, Karen
AU - Ager, Michael
N1 - © 2022. The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2022/8/8
Y1 - 2022/8/8
N2 - Sickle cell disease (SCD) is an inherited hemoglobin disorder characterized by the occlusion of small blood vessels by sickle-shaped red blood cells. SCD is associated with a number of complications, including ischemic priapism. While SCD accounts for at least one-third of all priapism cases, no definitive treatment strategy has been established to specifically treat patients with SC priapism. The aim of this systematic review was to assess the efficacy and safety of contemporary treatment modalities for acute and stuttering ischemic priapism associated with SCD. The primary outcome measures were defined as resolution of acute priapism (detumescence) and complete response of stuttering priapism, while the primary harm outcome was as sexual dysfunction. The protocol for the review has been registered (PROSPERO Nr: CRD42020182001), and a systematic search of Medline, Embase, and Cochrane controlled trials databases was performed. Three trials with 41 observational studies met the criteria for inclusion in this review. None of the trials assessed detumescence, as a primary outcome. All of the trials reported a complete response of stuttering priapism; however, the certainty of the evidence was low. It is clear that assessing the effectiveness of specific interventions for priapism in SCD, well-designed, adequately-powered, multicenter trials are strongly required.
AB - Sickle cell disease (SCD) is an inherited hemoglobin disorder characterized by the occlusion of small blood vessels by sickle-shaped red blood cells. SCD is associated with a number of complications, including ischemic priapism. While SCD accounts for at least one-third of all priapism cases, no definitive treatment strategy has been established to specifically treat patients with SC priapism. The aim of this systematic review was to assess the efficacy and safety of contemporary treatment modalities for acute and stuttering ischemic priapism associated with SCD. The primary outcome measures were defined as resolution of acute priapism (detumescence) and complete response of stuttering priapism, while the primary harm outcome was as sexual dysfunction. The protocol for the review has been registered (PROSPERO Nr: CRD42020182001), and a systematic search of Medline, Embase, and Cochrane controlled trials databases was performed. Three trials with 41 observational studies met the criteria for inclusion in this review. None of the trials assessed detumescence, as a primary outcome. All of the trials reported a complete response of stuttering priapism; however, the certainty of the evidence was low. It is clear that assessing the effectiveness of specific interventions for priapism in SCD, well-designed, adequately-powered, multicenter trials are strongly required.
KW - Anemia, Sickle Cell/complications
KW - Humans
KW - Male
KW - Pathologic Complete Response
KW - Priapism/etiology
KW - Reproductive Health
UR - http://www.scopus.com/inward/record.url?scp=85136803833&partnerID=8YFLogxK
U2 - 10.1038/s41443-022-00590-4
DO - 10.1038/s41443-022-00590-4
M3 - Article
C2 - 35941221
AN - SCOPUS:85136803833
SN - 0955-9930
VL - 36
SP - 20
EP - 35
JO - International Journal of Impotence Research
JF - International Journal of Impotence Research
IS - 1
ER -